Free Trial!
Today’s Best Stocks To Trade! Click Here
Innovative Solutions and Support Inc. (NASDAQ: ISSC | Quote | Chart | News | PowerRating) engages in the design, manufacture, and sale of flat panel display systems, flight information computers, and advanced monitoring systems in the United States. It offers flat panel displays or COCKPIT/IP, which displays various types of air data; engine and fuel data; altitude, heading, and navigational data; and alternative source information. The company also offers air data products that calculate and display various measures, such as aircraft speed, altitude, and rate of ascent and descent. In addition, it sells individual components, as well as partial and complete air data systems, including digital air data computers, integrated air data computers and display units, altitude displays, airspeed displays, and altitude alerters. Further, Innovative Solutions and Support develops engine and fuel displays, which convey information with respect to fuel and oil levels, and engine activity, such as oil and hydraulic pressure and temperature. Its customers include the Department of Defense, government agencies, defense contractors, commercial air transport carriers, original equipment manufacturers, and the corporate/general aviation markets. The company was founded in 1988 and is based in Exton, Pennsylvania. With 16.9 million shares outstanding and 2.41 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of ISSC. According to quarterly data provided by the SEC, there were still 18,771 shares of ISSC that were failing-to-deliver as of September 28, 2007.
Pinnacle Airlines Corp. (NASDAQ: PNCL | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the operation of a regional airline that provides airline capacity to Northwest Airlines, Inc. (Northwest) and Delta Air Lines, Inc. (Delta) in North America. The company operates an all-regional jet fleet and serves as a Northwest Airlink carrier at Northwest's domestic hub airports in Detroit, Minneapolis/St. Paul, and Memphis, as well as in Indianapolis. Pinnacle Airlines also operates as a Delta Connection carrier that provides airline capacity to Delta at its Atlanta hub. In addition, it has a regional airline that operates under partnership agreements with Continental Airlines, Inc. (Continental), United Air Lines, Inc. (United), and US Airways Group, Inc. (US Airways). Through the above partnership agreements, the company operates an all turboprop aircraft fleet and serves as a Continental Connection Carrier out of Houston/George Bush Intercontinental Airport, a United Express carrier out of Washington Dulles Airport, and as a US Airways Express carrier with operations at Pittsburgh, Boston, Washington Dulles, and New York/LaGuardia airports. As of December 31, 2007, it operated a jet fleet of 137 CRJ-200 aircraft as a Northwest Airlink carrier with approximately 770 daily departures to 115 cities in 36 states and 4 Canadian provinces, and 1 CRJ-900 aircraft as a Delta Connection carrier with approximately 6 daily departures to 4 cities in 4 states, as well as offered approximately 270 daily departures to 53 cities in 12 states. Pinnacle Airlines was founded in 1985 and is headquartered in Memphis, Tennessee. With 18.07 million shares outstanding and 4.28 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of PNCL. According to quarterly data provided by the SEC, there were still 16,490 shares of PNCL that were failing-to-deliver as of September 28, 2007.
Pluristem Therapeutics Inc. (NASDAQ: PSTI | Quote | Chart | News | PowerRating) engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel. With 6.69 million shares outstanding and 37,300 shares declared short as of May 2008, there is no longer a failure to deliver in shares of PSTI.
Trump Entertainment Resorts Inc. (NASDAQ: TRMP | Quote | Chart | News | PowerRating) engages in the ownership and operation of casino hotel properties in the United States. It offers gaming, casino resort, and entertainment services. As of December 31, 2007, the company operated three casino hotel properties comprising Trump Taj Mahal Casino Resort, Trump Plaza Hotel and Casino, and Trump Marina Hotel Casino in Atlantic City, New Jersey. Trump Entertainment Resorts was founded in 1995 and is based in Atlantic City, New Jersey. With 31.72 million shares outstanding and 6.94 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of TRMP. According to quarterly data provided by the SEC, there were still 40,093 shares of TRMP that were failing-to-deliver as of September 28, 2007.
Qiao Xing Universal Telephone Inc. (NASDAQ: XING | Quote | Chart | News | PowerRating) together with its subsidiaries, engages in the manufacture and distribution of telecommunications products primarily in the People's Republic China. It primarily manufactures mobile phone handsets under CECT and COSUN brands. The company also offers mobile phone accessories; terminals and equipment, including cord and cordless telephone sets; wireless fixed phones; Little Smart phones with removable cards; and VOIP phones. In addition, it sells fax machines; CDMA city-phones; CDMA inter-village phones; residential gateways; set-top-box products; and ADSL products. Qiao Xing Universal sells its products to local distributors, retail outlets, and end users through national and provincial distributors, as well as through direct-sales distributors. It has strategic partnerships with China Telecom, China Netcom, China Railcom, China Mobile, and China Unicom. The company was founded in 1992 and is based in Huizhou City, the People's Republic of China. With 29.65 million shares outstanding and 827,400 shares declared short as of May 2008, there is no longer a failure to deliver in shares of XING. According to quarterly data provided by the SEC, there were still 310,159 shares of XING that were failing-to-deliver as of September 28, 2007.
China Biopharma Inc. (OTCBB: CBPC | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the development and distribution of human vaccine products in China. It offers vaccines for flu, Japanese encephalitis, hepatitis B, allergies, and rabies. The company distributes its products directly or indirectly to hospitals, clinics, pension fund health programs, and center for disease control and prevention. China Biopharma was founded in 1997 and is based in Princeton, New Jersey. With 159.38 million shares outstanding and 1.54 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of CBPC. According to quarterly data provided by the SEC, there were still 747,824 shares of CBPC that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,000,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
